Fig 1. Study schedule for participants.
*Follow up by healthcare provider was conducted on day 42 (28 days after the second dose) for those in the intervention groups to monitor and document any adverse or severe adverse events.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.